Literature DB >> 6640538

Isozyme patterns of normal, benign, and malignant human breast tissues.

D Balinsky, C E Platz, J W Lewis.   

Abstract

Isozyme patterns of 23 different enzymes were compared in normal, benign, and malignant breast tissues; in MCF-7 cells; and in organoids of normal human breast tissue. Benign lesions generally showed isozyme patterns similar to those of normal tissues. Lactate dehydrogenase isozyme 5 was significantly increased in malignant tumors; MCF-7 cells had only lactate dehydrogenase (L-lactate:NAD oxidoreductase; EC 1.1.1.27). The mitochondrial form of malate dehydrogenase was also significantly increased in human malignant tumors; this was especially evident when comparing tumor and apparently uninvolved breast tissue from the same patient. The K4 isozyme of pyruvate kinase was the major form in most malignant breast tumors, but in only 41% of normal tissues, 30% of fibrocystic disease specimens, and 46% of fibroadenomas. A more anodal band of pyruvate kinase, probably a K3M or K3Kpm hybrid, predominated in most normal and benign tissues, but in only 63% of primary and 56% of secondary tumors. All specimens had predominantly creatine kinase BB, aldolase A4, and hexokinase I. Traces of aldolase A3C and of hexokinase II were observed in some tumors. None of the tumors had the Regan variant of alkaline phosphatase. The isozymes of lactate and malate dehydrogenases and of pyruvate kinase appear to be the most promising as putative tumor markers.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6640538

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  14 in total

1.  Molecular Pathways: Targeting Cellular Energy Metabolism in Cancer via Inhibition of SLC2A1 and LDHA.

Authors:  Aik T Ooi; Brigitte N Gomperts
Journal:  Clin Cancer Res       Date:  2015-04-02       Impact factor: 12.531

2.  Glycolytic reliance promotes anabolism in photoreceptors.

Authors:  Yashodhan Chinchore; Tedi Begaj; David Wu; Eugene Drokhlyansky; Constance L Cepko
Journal:  Elife       Date:  2017-06-09       Impact factor: 8.140

3.  Specific polypeptide differences in normal versus malignant human breast tissues by two-dimensional electrophoresis.

Authors:  P J Wirth; V Egilsson; V Gudnason; S Ingvarsson; S S Thorgeirsson
Journal:  Breast Cancer Res Treat       Date:  1987-11       Impact factor: 4.872

4.  A polymorphic variant of the lactate dehydrogenase B subunit in the rat.

Authors:  V Stolc
Journal:  Genetica       Date:  1987-05-15       Impact factor: 1.082

Review 5.  The role of phosphometabolites in cell proliferation, energy metabolism, and tumor therapy.

Authors:  S Mazurek; C B Boschek; E Eigenbrodt
Journal:  J Bioenerg Biomembr       Date:  1997-08       Impact factor: 2.945

Review 6.  Aerobic glycolysis by proliferating cells: protection against oxidative stress at the expense of energy yield.

Authors:  K Brand
Journal:  J Bioenerg Biomembr       Date:  1997-08       Impact factor: 2.945

7.  Role of malate dehydrogenase in facilitating lactate dehydrogenase to support the glycolysis pathway in tumors.

Authors:  Siavash Mansouri; Ali Shahriari; Hadi Kalantar; Taraneh Moini Zanjani; Mojtaba Haghi Karamallah
Journal:  Biomed Rep       Date:  2017-03-14

8.  Lactic dehydrogenase isozymes, 31P magnetic resonance spectroscopy, and in vitro antimitochondrial tumor toxicity with gossypol and rhodamine-123.

Authors:  C Benz; C Hollander; M Keniry; T L James; M Mitchell
Journal:  J Clin Invest       Date:  1987-02       Impact factor: 14.808

9.  Metabolic control analysis of cellular respiration in situ in intraoperational samples of human breast cancer.

Authors:  Tuuli Kaambre; Vladimir Chekulayev; Igor Shevchuk; Minna Karu-Varikmaa; Natalja Timohhina; Kersti Tepp; Jelena Bogovskaja; Riina Kütner; Vahur Valvere; Valdur Saks
Journal:  J Bioenerg Biomembr       Date:  2012-07-27       Impact factor: 2.945

10.  Lactate dehydrogenase B: a metabolic marker of response to neoadjuvant chemotherapy in breast cancer.

Authors:  Jennifer B Dennison; Jennifer R Molina; Shreya Mitra; Ana M González-Angulo; Justin M Balko; María G Kuba; Melinda E Sanders; Joseph A Pinto; Henry L Gómez; Carlos L Arteaga; Robert E Brown; Gordon B Mills
Journal:  Clin Cancer Res       Date:  2013-05-22       Impact factor: 12.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.